| Gene symbol | MGMT | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 10 | Map location | 10q26.3 | dbXrefs | |
| Description | O-6-methylguanine-DNA methyltransferase | ||||
| GTO ID | GTC1175 |
| Trial ID | NCT00005796 |
| Disease | Brain Cancer |
| Altered gene | MGMT |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | MGMT RTV PBSC |
| Co-treatment | filgrastim|lomustine|procarbazine hydrochloride|vincristine sulfate |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Study of Dose-Intensified Procarbazine, CCNU, Vincristine (PCV) for Poor Prognosis Pediatric and Adult Brain Tumors Utilizing Fibronectin-Assisted, Retroviral-Mediated Modification of CD34+ Peripheral Blood Cells With O6-Methylguanine DNA Methyltransferase |
| Year | 2000 |
| Country | United States |
| Company sponsor | Indiana University |
| Other ID(s) | 9607-22|IUMC-9607-22|NCI-H00-0049 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||